Flash Finance

Hindustan Bio Sciences Ltd532041Corporate

Software Products Latest results: Jun 2026 14 quarters of data
₹7.28
MCap ₹7 Cr
Hindustan Bio Sciences Ltd — Stock analysis & AI research Hindustan Bio Sciences Ltd — Live exchange announcements
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹0 Cr
Sales · Jun 2026
-100.0% YoY
₹-0 Cr
Operating Profit · Jun 2026
—
OPM % · Jun 2026
₹-0 Cr
Net Profit · Jun 2026
-1229.0% YoY
₹-0.11
EPS · Jun 2026
-1200.0% YoY

📝 Hindustan Bio Sciences Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Hindustan Bio Sciences Ltd reported revenue of ₹0 crore for the quarter ended June 2026 (Q1 FY27), down 100.0% from ₹0 crore in the same quarter last year.

The company reported a net loss of ₹0 crore, against a net profit of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.11.

Full year and trailing twelve months

For the full year FY26, Hindustan Bio Sciences Ltd posted revenue of ₹1 crore, a decline of 41.7% over FY25, with a net loss of ₹0 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹0 crore with a net loss of ₹0 crore.

Valuation snapshot

At the current price of ₹7.28, 532041 has a market capitalisation of ₹7 crore.

Within the Software Products industry, it is the 25th-largest of the 33 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 12.19%, public shareholders 87.81% of Hindustan Bio Sciences Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹7 Cr
Current Price ?
₹7.3
P/E ?
N/A
Industry P/E ?
26.30
P/B ?
8.77
P/S ?
19.16
P/FCF ?
26.96
Enterprise Value ?
₹10 Cr
EV/EBITDA ?
-45.23
PEG ?
N/A
Earnings Yield ?
-2.3%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹0 Cr
OPM ?
-56.0%
Profit after tax (TTM) ?
₹-0 Cr
EPS (TTM) ?
₹-0.21
ROCE ?
-2.4%
ROE ?
-25.7%
ROA ?
-6.7%
Growth
Sales — latest qtr ?
₹0 Cr
PAT — latest qtr ?
₹-0 Cr
YoY qtr sales growth ?
-100.0%
YoY qtr profit growth ?
-1,229.0%
Sales growth (3y) ?
-7%
Sales growth (5y) ?
-6%
Profit growth (3y) ?
N/A
Profit growth (5y) ?
14%
Financial Health
Debt ?
₹2 Cr
Debt to Equity ?
2.83
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
12.19%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-7.6%
Return 6 months ?
-6.7%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 00000000000000 -100.0% —
Operating Profit 0-000000-000-00-0-0 — -2.6%
Other Income 00000000000000 -100.0% —
Interest 00000000000000 — —
Depreciation 00000000000000 — —
Profit Before Tax 0-000000-000-00-0-0 -1229.0% -2.6%
Net Profit 0-000000-000-00-0-0 -1229.0% +5.9%
EPS 0.01-0.120.070.070.040.080.08-0.040.110.01-0.060.08-0.12-0.11 -1200.0% +8.3%
OPM % 6.1% — 18.8% 18.8% 10.3% 17.1% 17.1% — 26.3% 0.0% — 18.4% — — — —

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹1 Cr ₹1 Cr ₹0 Cr -41.7%
Operating Profit ₹0 Cr ₹-0 Cr ₹-0 Cr -150.0%
OPM % 16.67% -14.29% -56.03% -185.7%
NPM % 19.17% -12.86% -56.03% -167.1%
Other Income ₹0 Cr ₹0 Cr ₹0 Cr +33.3%
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr —
Interest ₹0 Cr ₹0 Cr ₹0 Cr —
EBIT ₹0 Cr ₹-0 Cr ₹-0 Cr -155.0%
PBT ₹0 Cr ₹-0 Cr ₹-0 Cr -130.4%
Tax — — ₹0 Cr —
Net Profit ₹0 Cr ₹-0 Cr ₹-0 Cr -139.1%
EPS ₹0.23 ₹-0.09 ₹-0.21 -139.1%
Material Cost — — ₹0 Cr —
Employee Cost — — ₹0 Cr —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 2.052.052.052.05 +0.0%
Reserves -1.30-1.25-1.15-1.22 -6.1%
Borrowings 2.462.562.512.35 -6.4%
Other Liabilities 0.080.010.010.02 +100.0%
Total Liabilities 3.293.373.423.20 -6.4%
Fixed Assets 0.030.030.030.01 -66.7%
CWIP 0.000.000.000.00 —
Investments 0.000.000.000.00 —
Other Assets 3.263.343.393.19 -5.9%
Total Assets 3.293.373.423.20 -6.4%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity -0.05-1.410.030.28 +833.3%
Cash from Investing Activity 0.000.000.00-0.01 —
Cash from Financing Activity 0.051.43-0.05-0.16 -220.0%
Net Cash Flow 0.000.03-0.020.12 +700.0%
Free Cash Flow -0.05-1.410.030.27 +800.0%
CFO/OP 167%-2,350%30%-467% -1656.7%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 178.53152.95198.2724.66 -87.6%
Inventory Days 0.000.000.000.00 —
Cash Conversion Cycle 178.53152.95198.2724.66 -87.6%
Working Capital Days -226.14312.86441.60305.81 -30.7%
ROCE % -1.30%1.52%2.95%-2.43% -182.4%

👥 Shareholding (latest 4 periods)

Metric Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 12.19%12.19%12.19%12.19% +0.0%
Public 87.81%87.81%87.80%87.81% +0.0%
No. of Shareholders 11,40511,51611,53011,707 +1.5%

⚖️ Peer comparison

Industry: Software Products · top 25 of 33 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 CAPILLARY Capillary Technologies ₹452.05 3,593 84.5 811 42 14.2% 5.2% — — 42.7% -1373.6%
2 501421 TechNVision Ventures ₹5,307.10 2,715 n/m 286 3 2.8% 1.0% 18.2% 90.9% 30.0% 9302.0%
3 539682 Mobavenue AI ₹123.65 2,104 190.2 24 5 33.9% 20.3% 313.3% 396.1% 120.8% 86.7%
4 539607 Blue Cloud ₹234.50 1,472 428.2 627 42 12.1% 6.7% 26.9% 19.6% -6.4% -13.4%
5 531525 ACE Software ₹327.60 315 135.2 58 4 10.3% 7.6% 79.5% -20.7% 7.9% -3.1%
6 531161 ABM Knowledgeware ₹190.87 314 63.7 105 10 14.8% 9.5% 7.0% -40.2% 4.2% -6.7%
7 526443 Artificial Electronics ₹83.14 194 4.6 193 49 34.2% 25.1% 476.9% 1133.3% 618.3% 1152.5%
8 512149 Avance Technologies ₹0.89 156 13.2 183 13 -0.3% 7.4% -7.0% 116.7% 63.9% 23.3%
9 538713 538713 — 155 — 57 6 14.7% 9.8% 9.1% 2.0% 10.8% -92.7%
10 511644 Omega Interactive ₹252.00 131 178.8 206 11 7.9% 5.4% 746200.0% 665.3% 268.6% 97.5%
11 512093 Cranes Software ₹5.99 103 — 7 -14 -41.6% -203.2% -16.3% -0.3% -1.7% 28.0%
12 530175 Odyssey Technologies ₹153.90 80 66.1 27 4 13.9% 13.7% 0.1% -7.2% -4.6% -60.1%
13 526709 Bits ₹5.72 76 81.5 2 1 47.8% 50.5% 30.1% 213.0% 40.5% 96.0%
14 509040 Netlink Solns(I) ₹142.20 46 17.7 0 2 -3275.0% 5075.0% -83.3% -62.1% 0.0% 99.0%
15 531268 B2B Software ₹38.77 38 21.8 31 3 8.7% 9.9% 26.2% 7.6% 14.2% 40.9%
16 531840 IEC Education ₹3.52 33 — — -3 — — — -833.3% — -25.0%
17 543578 Olatech Solutions ₹176.80 28 46.5 27 2 13.5% 6.4% — — 7.3% -175.8%
18 508867 New Markets ₹9.10 28 — 0 -0 -160.0% -160.0% -9.1% -1700.0% -100.0% -200.0%
19 537985 Infronics Systems ₹51.84 16 — — -1 — — -100.0% -166.1% -100.0% -139.0%
20 530595 TeleCanor Global ₹5.85 15 — 18 -2 36.9% -13.7% 308.5% -433.9% 166.8% -748.9%
21 538922 COSYN ₹42.47 15 265.4 11 0 10.4% 1.0% -26.5% -25.0% 49.5% -11.8%
22 538273 538273 — 15 — 27 2 9.3% 8.1% -21.7% 1.1% 8.5% 264.4%
23 530839 Clio Infotech ₹5.98 14 8.9 3 1 21.3% 24.5% 1793.3% 1000.0% 235.1% —
24 532100 Indo City ₹13.95 14 37.7 7 0 4.8% 5.6% -34.4% 123.2% 826.1% 21.0%
25 532041 Hindustan Bio ₹8.11 7 — 0 -0 -56.0% -56.0% -41.7% -139.1% -100.0% -1229.0%
❓ Frequently asked questions
What was Hindustan Bio Sciences Ltd's revenue in Q1 FY27?
Hindustan Bio Sciences Ltd reported revenue of ₹0 crore for the quarter ended June 2026 (Q1 FY27), down 100.0% from ₹0 crore in the same quarter last year.
What was Hindustan Bio Sciences Ltd's net profit in Q1 FY27?
The company reported a net loss of ₹0 crore, against a net profit of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.11.
What is 532041's market capitalisation and P/E ratio?
At the current price of ₹7.28, 532041 has a market capitalisation of ₹7 crore.
Who owns Hindustan Bio Sciences Ltd? (shareholding pattern)
As of Jun 2026, promoters held 12.19%, public shareholders 87.81% of Hindustan Bio Sciences Ltd.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI